Targeted reduction of CCR4(+) cells is sufficient to suppress allergic airway inflammation

BACK GROUND: Bronchial asthma is characterized by allergic airway inflammation involving C-C chemokine receptor type 4 (CCR4)-positive Th2 cells. As such, we hypothesize that the disease can be alleviated by targeted-elimination of CCR4(+) cells. Thymus and activation-regulated chemokine (TARC)-PE38...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Respir Investig
Egile Nagusiak: Honjo, Akifumi, Ogawa, Hirohisa, Azuma, Masahiko, Tezuka, Toshifumi, Sone, Saburo, Biragyn, Arya, Nishioka, Yasuhiko
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2013
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5846619/
https://ncbi.nlm.nih.gov/pubmed/24238232
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.resinv.2013.04.007
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak